4 February 2021
More and more the FDA is issuing warning letters as a result of laboratories not following current Good Documentation Practices (GDP). A lack of data integrity can lead to facility shutdown, import bans, recalls, lawsuits, and a drop in brand value and market share.
In this white paper, Abbott Informatics demonstrates how you can achieve compliance with the data integrity expectations of the Food and Drug Administration (FDA) as well as other regulatory authorities by utilizing a standalone version of STARLIMS Scientific Data Management System.
Download 10,000+